NASDAQ:REGN - Regeneron Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$422.51 +1.91 (+0.45 %)
(As of 02/20/2019 04:00 PM ET)
Previous Close$420.60
Today's Range$417.08 - $423.40
52-Week Range$281.89 - $431.32
Volume411,100 shs
Average Volume734,321 shs
Market Capitalization$46.17 billion
P/E Ratio21.34
Dividend YieldN/A
Beta1.27

Analyst Ratings

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
21 Wall Street analysts have issued ratings and price targets for Regeneron Pharmaceuticals in the last 12 months. Their average twelve-month price target is $404.8750, suggesting that the stock has a possible downside of 4.17%. The high price target for REGN is $483.00 and the low price target for REGN is $305.00. There are currently 1 sell rating, 13 hold ratings, 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.192.27
Ratings Breakdown: 1 Sell Rating(s)
13 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
13 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
15 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
14 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $404.8750$405.5294$403.6111$419.7727
Price Target Upside: 4.17% downside2.24% upside16.46% upside12.89% upside

Regeneron Pharmaceuticals (NASDAQ:REGN) Consensus Price Target History

Price Target History for Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals (NASDAQ:REGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/7/2019OppenheimerBoost Price TargetOutperform$440.00 ➝ $480.00LowView Rating Details
2/7/2019BMO Capital MarketsBoost Price TargetMarket Perform$412.00LowView Rating Details
2/6/2019Cantor FitzgeraldReiterated RatingHold$441.00HighView Rating Details
1/7/2019CowenReiterated RatingHold$385.00LowView Rating Details
1/4/2019GuggenheimUpgradeNeutral ➝ Buy$461.00HighView Rating Details
12/13/2018Goldman Sachs GroupUpgradeNeutral ➝ Conviction-BuyLowView Rating Details
12/7/2018Leerink SwannSet Price TargetBuy$473.00 ➝ $483.00LowView Rating Details
11/13/2018ArgusReiterated RatingBuyLowView Rating Details
11/7/2018JPMorgan Chase & Co.Set Price TargetHold$405.00MediumView Rating Details
10/11/2018Morgan StanleyBoost Price TargetEqual Weight$409.00 ➝ $412.00HighView Rating Details
10/11/2018Canaccord GenuityBoost Price TargetHold$390.00 ➝ $410.00HighView Rating Details
8/6/2018BarclaysBoost Price TargetUnderweight ➝ Underweight$290.00 ➝ $305.00LowView Rating Details
8/3/2018SunTrust BanksReiterated RatingHold$400.00LowView Rating Details
8/3/2018Robert W. BairdDowngradeOutperform ➝ NeutralLowView Rating Details
7/24/2018Jefferies Financial GroupReiterated RatingHold$340.00MediumView Rating Details
6/27/2018UBS GroupUpgradeMarket Perform ➝ OutperformHighView Rating Details
5/7/2018Royal Bank of CanadaLower Price TargetSector Perform$342.00LowView Rating Details
5/5/2018Credit Suisse GroupSet Price TargetBuy$420.00LowView Rating Details
4/9/2018Raymond JamesReiterated RatingOutperform ➝ Market PerformLowView Rating Details
3/13/2018BTIG ResearchReiterated RatingHoldMediumView Rating Details
3/13/2018Deutsche BankSet Price TargetHold$367.00MediumView Rating Details
1/9/2018CitigroupReiterated RatingNeutral ➝ Neutral$380.00 ➝ $388.00HighView Rating Details
11/16/2017Evercore ISILower Price TargetOutperform$605.00 ➝ $445.00N/AView Rating Details
11/13/2017Piper Jaffray CompaniesReiterated RatingBuy$540.00N/AView Rating Details
7/21/2017Bank of AmericaReiterated RatingBuy$589.00 ➝ $593.00LowView Rating Details
6/26/2017Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$410.00 ➝ $480.00LowView Rating Details
3/17/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformLowView Rating Details
(Data available from 2/20/2017 forward)
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel